4.7 Article

The role of interferon alpha in initiation of type I diabetes in the NOD mouse

期刊

CLINICAL IMMUNOLOGY
卷 140, 期 1, 页码 3-7

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2011.04.010

关键词

IFN-alpha; Plasmacytoid DC; Type 1 diabetes

资金

  1. Juvenile Diabetes Research Foundation (JDRF) [2007-745]
  2. Larry L. Hillblom Foundation [2008-D-030-FEL]

向作者/读者索取更多资源

Type 1 diabetes (T1D) is an autoimmune disease in both humans and the nonobese diabetic (NOD) mouse, in which the insulin-producing-cells of the pancreatic islets are destroyed by a beta islet cell-specific T cell immune response. We recently reported that interferon (IFN)-alpha is an early trigger of the T1D process in NOD mice. Here, we show that extensive blockade of IFN-alpha action by a monoclonal antibody specific to IFN-alpha receptor 1 results in nearly complete prevention of T1D in NOD mice. Whether professional IFN-alpha producing cells, plasmacytoid dendritic cells (pDCs), are responsible for the initiation of T1D has been unclear. Here we demonstrate that depletion of pDCs in NOD mice by a specific mAb given at 15-25 days of age significantly delays the onset and decreases the incidence of T1D. These findings indicate that pDC and pDC-derived IFN-alpha are the prime initiators of the pathogenesis of T1D in NOD mice. (C) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据